|
|
Volumn 42, Issue 9, 1998, Pages 2174-2177
|
|
Pharmacokinetics and distribution over the blood-brain barrier of zalcitabine (2',3'-dideoxycytidine) and BEA005 (2',3'-dideoxy-3'- hydroxymethylcytidine) in rats, studied by microdialysis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2',3' DIDEOXY 3' HYDROXYMETHYLCYTIDINE;
CYTIDINE DERIVATIVE;
OCTANOL;
PLASMA PROTEIN;
UNCLASSIFIED DRUG;
WATER;
ZALCITABINE;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD BRAIN BARRIER;
CONTROLLED STUDY;
DRUG BRAIN LEVEL;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG PROTEIN BINDING;
DRUG TISSUE LEVEL;
MALE;
MICRODIALYSIS;
MUSCLE;
NONHUMAN;
PARTITION COEFFICIENT;
PHARMACOKINETICS;
PRIORITY JOURNAL;
RAT;
SUBCUTANEOUS DRUG ADMINISTRATION;
|
|
EID: 0031663278
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/aac.42.9.2174 Document Type: Article |
|
Times cited : (17)
|
|
References (26)
|
